SB 1036, the "Oklahoma Triage, Treat, and Transport to Alternative Destination Act," requires health insurers in Oklahoma to cover specific ambulance services starting January 1, 2026. It mandates coverage for ambulance providers treating patients in place, triaging/treating/transporting to lower-acuity facilities (like urgent care or mental health centers), or for encounters resulting in no transport. This affects insurers, ambulance services, and people covered by health insurance plans. The law excludes hospitals, dialysis centers, and residential settings from "alternative destinations" and sets minimum reimbursement rates for ambulance services. It applies to all new or renewed health insurance contracts on or after the effective date.
SB 1040 amends Oklahoma law to update the appointment process for the Oklahoma Board of Licensed Alcohol and Drug Counselors. It removes an outdated requirement that five of six counselor members must have secured licensure by January 1, 2005, and instead mandates that at appointment, five members must be licensed counselors and one must be certified. The bill requires the Governor to appoint four members from a list provided by the Oklahoma Drug and Alcohol Professional Counselors Association, one from the Oklahoma Substance Abuse Services Alliance, and one from the Oklahoma Citizen Advocates for Recovery and Treatment Association. This change takes effect November 1, 2025, and affects how the board is composed, directly impacting the selection process for state-level alcohol and drug counseling oversight.
SB 1104 requires the Oklahoma Medical Marijuana Authority to select a vendor for a statewide inventory tracking system to monitor medical marijuana from cultivation to sale. The system must track key events like planting, harvesting, transportation, and disposal, and maintain detailed records of all products, including batches and transactions. This affects all medical marijuana businesses, research facilities, education centers, and waste disposal facilities, which must integrate their operations with the new system. The bill takes effect on November 1, 2025, aiming to standardize tracking and improve oversight.
SB 534 amends Oklahoma's medical marijuana transportation license rules to allow license holders to transport marijuana directly to patients, in addition to moving it between licensed facilities. This affects existing medical marijuana retailers, growers, and processors who hold transportation licenses. The key change requires all transported marijuana to be in a locked, clearly labeled container marked "Medical Marijuana or Derivative," and explicitly permits transport from licensed retailers to patients. The bill takes effect November 1, 2025, and does not create new licenses but modifies existing transportation provisions.
SB 959 would allow Oklahoma health care institutions (like hospitals and clinics) and health care payors (like insurers) to refuse services conflicting with their religious or moral beliefs, including declining to use facilities for such services. It grants legal immunity from lawsuits or retaliation (such as job loss, license denial, or contract termination) for these refusals, while requiring emergency care under federal law. Religious entities could also base hiring, staffing, and admission decisions on faith. The bill failed in committee on March 3, 2025, and did not become law.
SB 1064 requires health insurance plans in Oklahoma to use evidence-based clinical guidelines when creating step therapy protocols (where insurers mandate trying cheaper drugs first). It mandates that insurers provide a clear, accessible process for doctors and patients to request exceptions when step therapy blocks necessary medications, and they must grant exceptions if the doctor provides justification (e.g., prior drug failure, adverse reactions, or medical necessity). Insurers must respond to exception requests within 72 hours (24 hours for emergencies), and failure to respond on time automatically grants the exception. The bill directly affects insurers, healthcare providers, and patients using prescription drugs covered under step therapy protocols.
SB 161 requires pharmacy benefit managers (PBMs) operating in the state to uphold a specific fiduciary duty. This means PBMs must act in the best interests of patients, not just their own financial gain, when making decisions about drug coverage and pricing. The bill establishes new rules for how PBMs manage prescription drug benefits, mandating transparency and prioritizing patient welfare. It directly affects all PBMs providing services to health plans within the state, changing their operational obligations under current law.